ArticleCancer medicine2020

Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatment.

Sandy Srinivas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.